Combined γ-Tocotrienol and Erlotinib/Gefitinib Treatment Suppresses Stat and Akt Signaling in Murine Mammary Tumor Cells
- Author
- BACHAWAL, Sunitha V1 ; WALI, Vikram B1 ; SYLVESTER, Paul W1
[1] College of Pharmacy, University of Louisiana at Monroe, Monroe, LA 71209, United States - Source
Anticancer research. 2010, Vol 30, Num 2, pp 429-437, 9 p ; ref : 36 ref
- ISSN
- 0250-7005
- Scientific domain
- Medical oncology
- Publisher
- International Institute of Anticancer Research, Attiki
- Publication country
- Greece
- Document type
- Article
- Language
- English
- Author keyword
- Akt ErbB receptors Stat breast cancer erlotinib gefitinib tyrosine kinase inhibitors vitamin E γ-tocotrienol
- Keyword (fr)
- Akt protein kinase Animal Anticancéreux Cancer du sein Cancérologie Cellule tumorale Erlotinib Facteur transcription STAT Géfitinib Protein-tyrosine kinase Récepteur biologique Souris Traitement Transduction signal Vitamine E Cancer Dérivé de la quinazoline Enzyme Inhibiteur de la tyrosine kinase Inhibiteur enzyme Mammalia Pathologie de la glande mammaire Pathologie du sein Rodentia Transferases Tumeur maligne Vertebrata
- Keyword (en)
- Akt protein kinase Animal Antineoplastic agent Breast cancer Cancerology Tumor cell Erlotinib Transduction factor STAT Gefitinib Protein-tyrosine kinase Biological receptor Mouse Treatment Signal transduction Vitamin E Cancer Quinazoline derivatives Enzyme Tyrosine kinase inhibitor Enzyme inhibitor Mammalia Mammary gland diseases Breast disease Rodentia Transferases Malignant tumor Vertebrata
- Keyword (es)
- Akt protein kinase Animal Anticanceroso Cáncer del pecho Cancerología Célula tumoral Erlotinib Factor transcripción STAT Gefitinib Protein-tyrosine kinase Receptor biológico Ratón Tratamiento Transducción señal Vitamina E Cáncer Enzima Inhibidor tyrosine kinase Inhibidor enzima Mammalia Glándula mamaria patología Seno patología Rodentia Transferases Tumor maligno Vertebrata
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20E Mammary gland diseases / 002B20E02 Tumors
- Discipline
- Gynecology. Andrology. Obstetrics Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 22509126
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:121:\"Combined \u03b3-Tocotrienol and Erlotinib\/Gefitinib Treatment Suppresses Stat and Akt Signaling in Murine Mammary Tumor Cells\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Anticancer research\";s:9:\"\u0000*\u0000stitle\";s:14:\"Anticancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"429\";s:8:\"\u0000*\u0000epage\";s:3:\"437\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0250-7005\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BACHAWAL\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Sunitha V\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:14:\"WALI, Vikram B\";i:1;s:17:\"SYLVESTER, Paul W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:121:\"Combined \u03b3-Tocotrienol and Erlotinib\/Gefitinib Treatment Suppresses Stat and Akt Signaling in Murine Mammary Tumor Cells\";s:8:\"\u0000*\u0000place\";s:6:\"Attiki\";s:6:\"\u0000*\u0000pub\";s:46:\"International Institute of Anticancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:121:\"Combined \u03b3-Tocotrienol and Erlotinib\/Gefitinib Treatment Suppresses Stat and Akt Signaling in Murine Mammary Tumor Cells\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Anticancer research\";s:9:\"\u0000*\u0000stitle\";s:14:\"Anticancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"429\";s:8:\"\u0000*\u0000epage\";s:3:\"437\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0250-7005\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BACHAWAL\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Sunitha V\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:14:\"WALI, Vikram B\";i:1;s:17:\"SYLVESTER, Paul W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:121:\"Combined \u03b3-Tocotrienol and Erlotinib\/Gefitinib Treatment Suppresses Stat and Akt Signaling in Murine Mammary Tumor Cells\";s:8:\"\u0000*\u0000place\";s:6:\"Attiki\";s:6:\"\u0000*\u0000pub\";s:46:\"International Institute of Anticancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:121:\"Combined \u03b3-Tocotrienol and Erlotinib\/Gefitinib Treatment Suppresses Stat and Akt Signaling in Murine Mammary Tumor Cells\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Anticancer research\";s:9:\"\u0000*\u0000stitle\";s:14:\"Anticancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"429\";s:8:\"\u0000*\u0000epage\";s:3:\"437\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0250-7005\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BACHAWAL\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Sunitha V\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:14:\"WALI, Vikram B\";i:1;s:17:\"SYLVESTER, Paul W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:121:\"Combined \u03b3-Tocotrienol and Erlotinib\/Gefitinib Treatment Suppresses Stat and Akt Signaling in Murine Mammary Tumor Cells\";s:8:\"\u0000*\u0000place\";s:6:\"Attiki\";s:6:\"\u0000*\u0000pub\";s:46:\"International Institute of Anticancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:121:\"Combined \u03b3-Tocotrienol and Erlotinib\/Gefitinib Treatment Suppresses Stat and Akt Signaling in Murine Mammary Tumor Cells\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Anticancer research\";s:9:\"\u0000*\u0000stitle\";s:14:\"Anticancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"429\";s:8:\"\u0000*\u0000epage\";s:3:\"437\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0250-7005\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BACHAWAL\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Sunitha V\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:14:\"WALI, Vikram B\";i:1;s:17:\"SYLVESTER, Paul W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:121:\"Combined \u03b3-Tocotrienol and Erlotinib\/Gefitinib Treatment Suppresses Stat and Akt Signaling in Murine Mammary Tumor Cells\";s:8:\"\u0000*\u0000place\";s:6:\"Attiki\";s:6:\"\u0000*\u0000pub\";s:46:\"International Institute of Anticancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:121:\"Combined \u03b3-Tocotrienol and Erlotinib\/Gefitinib Treatment Suppresses Stat and Akt Signaling in Murine Mammary Tumor Cells\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Anticancer research\";s:9:\"\u0000*\u0000stitle\";s:14:\"Anticancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"429\";s:8:\"\u0000*\u0000epage\";s:3:\"437\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0250-7005\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BACHAWAL\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Sunitha V\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:14:\"WALI, Vikram B\";i:1;s:17:\"SYLVESTER, Paul W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:121:\"Combined \u03b3-Tocotrienol and Erlotinib\/Gefitinib Treatment Suppresses Stat and Akt Signaling in Murine Mammary Tumor Cells\";s:8:\"\u0000*\u0000place\";s:6:\"Attiki\";s:6:\"\u0000*\u0000pub\";s:46:\"International Institute of Anticancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
